References

1. Scand J Gastroenterol v.10 The small intestinal disaccharidase activity in ulcerative colitis Gudmand-Hoyer E;Binder V;Soltoft J
2. Gut v.35 Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives Munkholm P;Langholz E;Hollander D;Thornberg K
3. Gastroenterology v.101 Intestinal immune reactivity to interleukin-2 differs among Crohn's disease, ulcerative colitis, and controls Kusugami K;Youngman KR;West GA
4. J Gastroenterol Hepatol v.14 Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease Hosokawa T;Kusugami K;Ina K
5. Med J Rec v.122 Gastrointestinal manifestations of food allergy Andresen AFR
6. Am J Dig Dis v.9 Ulcerative colitis-an allergic phenomenon Andresen AFR
7. Ann Intern Med v.17 Chronic ulcerative colitis-allergic in its etiology Rowe AH
8. Gastroenterology v.115 Inflammatory bowel disease: Etiology and pathogenesis Fiocchi C
9. Digestion v.59 Spectrum of cytokine gene expression in intestinal mucosal lesions of Crohn's disease and ulcerative colitis Funakosi K(et al.)
10. Intern Med v.37 Correleations between interleukin-8, and myelperoxidase or luminol-dependent chemiluinescence in inflamed mucosa of ulcerative colitis Anezaki(et al.)
11. Digestion v.56 Activated CD4+ and CD8+ cell in the colonic mucosa of ulcerative colitis patient: Their relationship to HLA-DR antigen expression on the colonic epithelium and serum soluble Cd25 levels Sasakawa T;Takizawa H;Bannai H(et al.)
12. Gut v.33 Detection of m RNAs for macrophage products in inflammatory bowel disease by in site hybridization Cappello M;Keshav S;Prince C(et al.)
13. Gastroenterology v.106 Cytokine inintestinal inflammation: Pathophysiological and clinical considerations Sartor RB
14. Gastroenterology v.106 Impared response of activated mononuclear phagicytes Schreiber S;Heinig T;Panzer U(et al.)
15. Am J Gastroenterol v.82 Mucosal interleukin-8 is involoved in netrophil migration and binding to extracellular matrix in inflammatory bowel disease Ina K;Kusugami K;Yamaguchi T(et al.)
16. Gastroenterology v.109 Treatment of Crohn's disease with antitumor necrosis factor chimeric monoclonal antibody (cA2) Van Dullenmen HM;Van Deventer SJH;Hommes DW(et al.)
17. Dig Dis Sci v.40 Up-regulation of E-selectin and intercellualr adhesion molecule-1 differs between Crohn's disease and ulcerative colitis Pooley N;Ghosh L;Sharon P
18. Essentials of mucosal immunology Intestinal epithelial cells: an integral component of the mucosal immune system Kagnoff MF;Eckmann L;Yang SK(et al.);Kagnoff MF(ed.);Kiyono H(ed.)
19. Gastroenterology v.97 Inflammatory mediators of experimental colitis in rats Rachmilewitz D;Simon PL;Schwartz LW(et al.)
20. Digestion v.56 Activated immunocompetent cells in rat colitis mucosa induced bt dextran sulfate sodium and not complete but partial suppresion of colitis by FK 506 Takizawa H;Shintani N;Natsui M(et al.)
21. Cytokine in inflammatory bowel disease Cytokine networks in animal models in intestinal inflammation Vantol EAF;Sartor RB;Fiocchi C(ed.)
22. Clin Exp Immunol v.107 Neutralization of tumor necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextransulphate sodium-induced colitis in mice Kojouharaff G;Hans W;Obermeier F(et al.)
23. Nature Medicine v.82 Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-$^kB$ abrogates established experimental colitis in mice Newrath MF;Pettersson S;Meyer zum Buschenfeld KH(et al.)